Sunday, June 30, 2024

Seal Shield to Showcase Shyld AI, the World’s First Intelligent, Autonomous, UV-C Disinfection System at HIMSS 2024

Related stories

Beroe Makes Strategic Investment in Forestreet, Strengthening AI Capabilities and Driving Procurement Intelligence Innovation

Deal builds out Beroe's leadership in category-level procurement intelligence, with the addition...

Marvell Extends Connectivity Leadership With Industry’s First 1.6T PAM4 DSP for Active Electrical Cables

Marvell Technology, Inc., a leader in data infrastructure semiconductor...

Trellix Named an XDR Market Leader

Trellix Platform excels in scalability, flexibility, and integration capabilities...
spot_imgspot_img

Seal Shield, a global leader in healthcare technology, is proud to showcase Shyld AI at the upcoming HIMSS 2024 conference in Orlando, Florida, from March 11th to 15th. Shyld AI is the world’s first autonomous and intelligent UV-C disinfection system, a breakthrough technology which has been successfully piloted at Stanford Healthcare.

The innovative Shyld disinfection system employs advanced AI technology to detect contamination, and autonomously, safely, disinfect hard, non-porous surfaces within a room. Utilizing UV-C LED technology, Shyld AI delivers a high-intensity, collimated beam of UV light to contaminated surfaces, ensuring thorough disinfection without any of the material degradation or noxious odors associated with mercury based, UV robots. This method not only improves hospital room turn-time but also significantly reduces the labor traditionally required for manually operated UV disinfection robots, thereby cutting costs, and improving efficiency.

The pilot at Stanford Healthcare has solidified Shyld AI’s role as a game-changer in healthcare disinfection. This pilot in the Emergency Department, one of the most chaotic areas of the hospital, has already shown immense benefits from labor savings and reduced down-time. The outcomes from the Stanford Healthcare pilot have been exciting, resulting in Stanford  growing their Shyld AI fleet to over 20 units. This initial pilot has successfully demonstrated Shyld AI’s potential to set a new standard of care by enhancing environmental safety.

Also Read: IPA’s subsidiary BioStrand Unveils Major Breakthrough in Life Sciences with Advanced Foundation AI Model Utilizing LLM Stacking and HYFT Technology

“At Seal Shield, we are dedicated to enhancing environmental safety in hospitals through innovative technology,” said Brad Whitchurch, Seal Shield CEO. “We believe UV-C adoption is critical towards the evolution of infection control. Seal Shield has been a pioneer in UV-C disinfection since it introduced the ElectroClave UV-C disinfection solution in 2016. Our recent acquisition of CleanSlate UV, and now the introduction of the Shyld AI autonomous UV disinfection system, adds to our growing portfolio of intelligent UV-C solutions. In the past year alone, we’ve grown our UV install base to 3000+ locations across over 750 hospitals, harnessing the advantages of UV disinfection in healthcare.”

Healthcare customers and investor prospects can experience Shyld AI’s transformative technology firsthand by visiting Seal Shield booth #4873 at HIMSS 2024, where live demonstrations will highlight the system’s intelligent disinfection process and smart capabilities.

SOURCE: PRNewswire

Subscribe

- Never miss a story with notifications


    Latest stories

    spot_img